ISIS drug is better, approved, safer, much less blood monitoring and none of the GI issues like diarrhea.
As I mentioned, commercial activities are underway. We have a sales force that is now detailing this drug with a simple message. The message for this drug is, this is an at home, weekly, subcu injection. It’s a drug that does not require a low fat diet. It’s a drug that does not require multiple vitamin co-supplements. Also important is patients with homozygous FH are sick patients.